Clinical Trial Update: A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer

View source ↗

Summary

This clinical trial outlines a personalized management pathway for locally advanced and borderline resectable pancreatic cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Resectable Pancreatic Cancer
• Pancreatic Cancer

Snippet

Sponsor: Oslo University Hospital | Conditions: Locally Advanced Pancreatic Cancer, Borderline Resectable Pancreatic Cancer | Status: RECRUITING